This work demonstrated reductions in behavioral responses to peripheral inflammation after i.t. injection of a drug that reversed obesity-induced PPARα downregulation in spinal cord, even though the treatment did not affect metabolic parameters. The gene discussed is PPARA; the disease is Obesity.